Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features
© The Author(s) 2023. Published by Oxford University Press..
BACKGROUND: Accurate prognostic stratification of hepatocellular carcinoma (HCC) is vital for clinical trial enrollment and treatment allocation. Multiple scoring systems have been created to predict patient survival, but no standardized scoring systems account for radiologic tumor features. We sought to create a generalizable scoring system for HCC which incorporates standardized radiologic tumor features and more accurately predicts overall survival (OS) than established systems.
METHODS: Clinicopathologic parameters were collected from a prospectively collected cohort of patients with HCC treated at a single institution. Imaging studies were evaluated for tumor characteristics. Patients were randomly divided into a training set for identification of covariates that impacted OS and a validation set. Cox models were used to determine the association of various factors with OS and a scoring system was created.
RESULTS: We identified 383 patients with HCC with imaging and survival outcomes, n = 255 in the training set and 128 in the validation cohort. Factors associated with OS on multivariate analysis included: tumor margin appearance on CT or MRI (hazard ratio [HR] 1.37, 95% CI, 1.01-1.88) with infiltrative margins portending worse outcomes than encapsulated margins, massive tumor morphology (HR 1.64, 95% CI, 1.06-2.54); >2 lesions (HR 2.06, 95% CI, 1.46-2.88), Child-Turcotte-Pugh class C (HR 3.7, 95% CI, 2.23-6.16), and portal vein thrombus (HR 2.41, 95% CI, 1.71-3.39). A new scoring system was developed and more predictive of OS than other well-established systems.
CONCLUSIONS: Incorporation of standardized imaging characteristics to established clinical and lab predictors of outcome resulted in an improved predictive scoring system for patients with HCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
The oncologist - (2023) vom: 30. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tran Cao, Hop S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Digestive system neoplasms |
|---|
| Anmerkungen: |
Date Revised 30.12.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1093/oncolo/oyad329 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366498967 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366498967 | ||
| 003 | DE-627 | ||
| 005 | 20240108140955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/oncolo/oyad329 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1246.xml |
| 035 | |a (DE-627)NLM366498967 | ||
| 035 | |a (NLM)38159256 | ||
| 035 | |a (PII)oyad329 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tran Cao, Hop S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press. | ||
| 520 | |a BACKGROUND: Accurate prognostic stratification of hepatocellular carcinoma (HCC) is vital for clinical trial enrollment and treatment allocation. Multiple scoring systems have been created to predict patient survival, but no standardized scoring systems account for radiologic tumor features. We sought to create a generalizable scoring system for HCC which incorporates standardized radiologic tumor features and more accurately predicts overall survival (OS) than established systems | ||
| 520 | |a METHODS: Clinicopathologic parameters were collected from a prospectively collected cohort of patients with HCC treated at a single institution. Imaging studies were evaluated for tumor characteristics. Patients were randomly divided into a training set for identification of covariates that impacted OS and a validation set. Cox models were used to determine the association of various factors with OS and a scoring system was created | ||
| 520 | |a RESULTS: We identified 383 patients with HCC with imaging and survival outcomes, n = 255 in the training set and 128 in the validation cohort. Factors associated with OS on multivariate analysis included: tumor margin appearance on CT or MRI (hazard ratio [HR] 1.37, 95% CI, 1.01-1.88) with infiltrative margins portending worse outcomes than encapsulated margins, massive tumor morphology (HR 1.64, 95% CI, 1.06-2.54); >2 lesions (HR 2.06, 95% CI, 1.46-2.88), Child-Turcotte-Pugh class C (HR 3.7, 95% CI, 2.23-6.16), and portal vein thrombus (HR 2.41, 95% CI, 1.71-3.39). A new scoring system was developed and more predictive of OS than other well-established systems | ||
| 520 | |a CONCLUSIONS: Incorporation of standardized imaging characteristics to established clinical and lab predictors of outcome resulted in an improved predictive scoring system for patients with HCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a digestive system neoplasms | |
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a liver neoplasms | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a radiology | |
| 700 | 1 | |a Witt, Russell G |e verfasserin |4 aut | |
| 700 | 1 | |a Elsayes, Khaled M |e verfasserin |4 aut | |
| 700 | 1 | |a Baiomy, Ali A |e verfasserin |4 aut | |
| 700 | 1 | |a Xiao, Lianchun |e verfasserin |4 aut | |
| 700 | 1 | |a Palmquist, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Sunyoung S |e verfasserin |4 aut | |
| 700 | 1 | |a Mohamed, Yehia I |e verfasserin |4 aut | |
| 700 | 1 | |a Mahvash, Armeen |e verfasserin |4 aut | |
| 700 | 1 | |a Tzeng, Ching-Wei D |e verfasserin |4 aut | |
| 700 | 1 | |a Chun, Yun Shin |e verfasserin |4 aut | |
| 700 | 1 | |a Koay, Eugene Jon |e verfasserin |4 aut | |
| 700 | 1 | |a Rashid, Asif |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Manal M |e verfasserin |4 aut | |
| 700 | 1 | |a Yao, James C |e verfasserin |4 aut | |
| 700 | 1 | |a Vauthey, Jean-Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Kaseb, Ahmed O |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The oncologist |d 1998 |g (2023) vom: 30. Dez. |w (DE-627)NLM095483306 |x 1549-490X |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:30 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/oncolo/oyad329 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 30 |c 12 | ||